semaglutide revive rx GLP-1s | AgelessRx
Description
NICE recommends GLP-1 therapies for adults with BMI 35 kg/m or BMI 3034.9 kg/m with weight-related comorbidities, limited to 2 years' treatment
Tirzepatide has the potential benefit of improving metabolic control and cardiovascular function because of its dual activity on GIP and GLP-1 receptors
Take 1 minute to answer a few yes or no questions that help to assess if you might be a candidate for PRP, stem cell or other nonsurgical regenerative treatments
Simple lifestyle changes can also make a difference
Certain conditions make semaglutide unsuitable
Whether you are dispensing Retatrutide, Tirzepatide, or other GLP-1 peptides , this device ensures unparalleled dose accuracy and patient comfort
